Amyris, Inc. (AMRS) |
|
0.05 -0.014 (-21.88%)
|
08-18 16:00 |
|
Open: |
0.064 |
Pre. Close: |
0.064 |
|
High:
|
0.0642 |
Low:
|
0.05 |
|
Volume:
|
46,746,028 |
Market Cap:
|
18(M) |
|
|
|
Technical analysis |
as of: 2023-09-29 4:25:49 PM |
|
Short-term rate:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
|
Mid-term rate:
|
 |
| Target: |
Six months: 0.07  One year: 0.09 |
| Support: |
Support1: 0.03 Support2: 0.02 |
| Resistance: |
Resistance1: 0.06 Resistance2: 0.08 |
| Pivot: |
0.04 |
| Moving Average: |
MA(5): 0.04 MA(20): 0.04
MA(100): 0.65 MA(250): 1.32 |
| MACD: |
MACD(12,26): -0.1 Signal(9): -0.2 |
| Stochastic oscillator: |
%K(14,3): 73.4 %D(3): 73.9 |
| RSI: |
RSI(14): 29.5 |
| 52-week: |
High: 3.48 Low: 0.03 |
| Average Vol(K): |
3-Month: 24,360 (K) 10-Days: 1,266 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ AMRS ] has closed It is unclear right now based on current values. 96.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 16 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.06 - 0.06 |
0.06 - 0.06 |
|
Low:
|
0.04 - 0.04 |
0.04 - 0.04 |
|
Close:
|
0.05 - 0.05 |
0.05 - 0.05 |
|
Company Description |
|
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California. |
Headline News |
Thu, 21 Sep 2023
E'ville Biz: Upside Foods Scrutinized, JDE Peet's Criticized For ... - evilleeye.com
Wed, 09 Aug 2023
AMYRIS ANNOUNCES OPERATIONAL AND FINANCIAL ... - PR Newswire
Mon, 26 Jun 2023
AMYRIS ANNOUNCES CEO TRANSITION AND GLOBAL ... - PR Newswire
Fri, 26 May 2023
AMYRIS, INC. : Notice of Delisting or Failure to Satisfy a Continued ... - Marketscreener.com
Fri, 19 May 2023
Individual investors account for 38% of Amyris, Inc.'s (NASDAQ:AMRS) ownership, while institutions account for 31% - Yahoo Finance
Fri, 19 May 2023
AMYRIS COMPLETES LICENSE FOR SUPPLY OF SUSTAINABLE ... - PR Newswire
|
Financial Analysis |
| Price to Book Value: |
Underperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Outperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Underperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Basic Materials |
| Industry: Specialty Chemicals |
| Shares Out. |
369 (M) |
| Shares Float |
261 (M) |
|
% Held by Insiders
|
5.8 (%) |
|
% Held by Institutions
|
54.1 (%) |
|
Shares Short
|
64,200 (K) |
|
Shares Short P.Month
|
57,800 (K) |
Stock Financials |
|
EPS
|
-1.16 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
-1.8 |
|
Profit Margin (%)
|
-229.2 |
|
Operating Margin (%)
|
-218.4 |
|
Return on Assets (ttm)
|
-46.5 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
-2.8 |
|
Gross Profit (p.s.)
|
-0.27 |
|
Sales Per Share
|
0.72 |
|
EBITDA (p.s.)
|
-1.54 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-463 (M) |
|
Levered Free Cash Flow
|
-313 (M) |
Stock Valuations |
|
PE Ratio
|
-0.05 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
-0.04 |
|
Price to Sales
|
0.07 |
|
Price to Cash Flow
|
-0.05 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
